NIH-funded research R01 grant

Understanding the cellular interactions and molecular changes in ALS

Official title: Spatially Resolved Dynamics of Molecular Pathology and Intercellular Interactions in Amytrophic Lateral Sclerosis

Funded at New York Genome Center · NIH-10771178 · Data updated 2026-11-12

This study is looking at how different brain and spinal cord cells interact in people with ALS to better understand the disease and find new ways to diagnose and treat it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Genome Center
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 1, 2020
Project endJanuary 31, 2026
Funding year2024
Award (this year)$526,777
NIH project number5R01NS116350-05
Project IDNIH-10771178 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Amyotrophic Lateral Sclerosis.

Less likely to help

Patients with other neurodegenerative diseases or those without a diagnosis of ALS may not benefit from this research.

What this research studies

This research investigates the complex interactions between different cell types in the brain and spinal cord of patients with Amyotrophic Lateral Sclerosis (ALS). By creating a detailed map of the molecular changes and spatial organization of these cells, the study aims to uncover how these factors contribute to the progression of ALS. The researchers will utilize advanced techniques to analyze the transcriptome and proteome of cellular subpopulations, comparing those from ALS patients to healthy controls. This approach may help identify new diagnostic markers and therapeutic targets for ALS.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for ALS patients.

How similar studies have gone: Previous research has shown promise in understanding neurodegenerative diseases through similar multi-omics approaches, indicating potential for success in this area.

Where this research is happening

  • New York Genome Center
    New York, United States
    Active

Researchers

  • Principal investigator: Phatnani, Hemali — New York Genome Center
  • Study coordinator: Phatnani, Hemali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.